31,556 Shares in Axcelis Technologies, Inc. $ACLS Bought by Great Lakes Advisors LLC

Key Points

• Great Lakes Advisors LLC acquired 31,556 Axcelis Technologies shares during the second quarter, worth approximately $5.98 million and representing about 0.10% of the company. Institutional investors collectively own nearly 90% of ACLS.
• Axcelis reported quarterly earnings of $1.06 per share, beating estimates of $0.89, while revenue rose 10.6% year over year to $215.18 million. The company guided for third-quarter EPS of $1.11.
• Insiders sold 4,512 shares worth $713,682 during the latest quarter, while analysts maintain a consensus “Hold” rating with an average price target of $132.20.

Great Lakes Advisors LLC acquired a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 31,556 shares of the semiconductor company's stock, valued at approximately $5,978,000. Great Lakes Advisors LLC owned approximately 0.10% of Axcelis Technologies at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ACLS. Victory Capital Management Inc. lifted its position in shares of Axcelis Technologies by 85.9% during the fourth quarter. Victory Capital Management Inc. now owns 1,807,404 shares of the semiconductor company's stock valued at $145,207,000 after buying an additional 835,242 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Axcelis Technologies by 3,402.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company's stock worth $45,772,000 after buying an additional 477,705 shares during the last quarter. Invesco Ltd. grew its position in shares of Axcelis Technologies by 176.6% in the 3rd quarter. Invesco Ltd. now owns 386,735 shares of the semiconductor company's stock worth $37,761,000 after buying an additional 246,939 shares during the last quarter. Balyasny Asset Management L.P. raised its stake in shares of Axcelis Technologies by 10,368.7% during the 4th quarter. Balyasny Asset Management L.P. now owns 243,503 shares of the semiconductor company's stock worth $19,563,000 after acquiring an additional 241,177 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of Axcelis Technologies during the 2nd quarter worth approximately $38,830,000. Hedge funds and other institutional investors own 89.98% of the company's stock.

Insider Buying and Selling

In other Axcelis Technologies news, EVP Eileen Evans sold 926 shares of Axcelis Technologies stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $155.51, for a total transaction of $144,002.26. Following the completion of the sale, the executive vice president directly owned 31,295 shares in the company, valued at approximately $4,866,685.45. The trade was a 2.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Todd Sutton sold 2,000 shares of the company's stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $159.99, for a total transaction of $319,980.00. Following the completion of the sale, the vice president directly owned 6,360 shares in the company, valued at $1,017,536.40. This trade represents a 23.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 4,512 shares of company stock worth $713,682. 0.49% of the stock is owned by company insiders.

Axcelis Technologies Stock Performance

Shares of ACLS stock opened at $126.43 on Thursday. The firm has a market capitalization of $3.90 billion, a price-to-earnings ratio of 42.43, a price-to-earnings-growth ratio of 4.14 and a beta of 1.92. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21. The business has a fifty day moving average of $149.36 and a 200 day moving average of $127.13. Axcelis Technologies, Inc. has a 1 year low of $73.60 and a 1 year high of $193.78.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.17. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%.The business had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. During the same period in the prior year, the company earned $1.13 earnings per share. The company's revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, research analysts expect that Axcelis Technologies, Inc. will post 3.39 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on ACLS. Bank of America increased their price objective on Axcelis Technologies from $130.00 to $156.00 and gave the company an "underperform" rating in a report on Tuesday, June 23rd. Craig Hallum cut Axcelis Technologies from a "buy" rating to a "hold" rating and set a $140.00 price target for the company. in a research note on Friday, August 7th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Three investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $132.20.

Axcelis Technologies Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company's product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source